Hematopoietic cell transplantation is a curative treatment for a variety of hematologic
diseases. Advances in transplantation technology have reduced early transplant-related …

Background Improvements in diagnostics and treatment for paediatric malignancies resulted
in a major increase in survival. However, childhood cancer survivors (CCS) are at risk of …

Background and objectives: Thrombotic microangiopathy (TMA) is a known complication of
hematopoietic cell transplantation (HCT). The etiology and diagnosis of TMA in this patient …

Hematopoietic stem cell transplantation is a life-saving therapy for many patients with
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …

We conducted a cohort study to identify risk factors of chronic kidney disease (CKD) among
long-term survivors of hematopoietic cell transplant (HCT). We studied 1635 patients …

The conditioning regimen prior to stem cell transplantation in 36 patients with high-risk acute
myeloid leukemia (AML) and myelodysplastic syndrome (MDS) was intensified by treating …

Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk
factors. Background Survival after myeloablative therapy followed by hematopoietic cell …

High-dose myeloablative hematopoietic cell transplantation is becoming an increasingly
common treatment modality for a variety of diseases. Patient survival may be limited by …

Since more and more children survive allogeneic bone marrow transplantation (BMT),
knowledge of acute and late complications becomes increasingly important. Besides the …

Urinalysis showed 1 proteinuria, many red blood cells, one epithelial cell cast, and 0 to 2
granular casts per low-power field. A spot urine specimen showed 316 mg of protein per …